Get started
Progyny, Inc.Progyny, Inc.Progyny, Inc.

Progyny, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

PGNY chart


Full chart

PGNY upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.89 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
39.07
Basic EPS (TTM)
0.59 USD
Net income (FY)
‪54.34 M‬ USD
Revenue (FY)
‪1.17 B‬ USD
Shares float
‪71.60 M‬
Beta (1Y)
0.48

Employees


Employees (FY)
680
Change (1Y)
+114 +20.14%
Revenue / Employee (1Y)
‪1.72 M‬ USD
Net income / Employee (1Y)
‪79.91 K‬ USD

About Progyny, Inc.


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Peter Anevski
Website
progyny.com
Headquarters
New York
Founded
2008
FIGI
BBG002H1K1H1
Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PGNY news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as PGNY.

Frequently Asked Questions


The current price of PGNY is 21.81 USD — it has decreased by −1.15% in the past 24 hours. Watch Progyny, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Progyny, Inc. stocks are traded under the ticker PGNY.
PGNY stock has fallen by −1.07% compared to the previous week, the month change is a 9.23% rise, over the last year Progyny, Inc. has showed a −36.60% decrease.
We've gathered analysts' opinions on Progyny, Inc. future price: according to them, PGNY price has a max estimate of 34.00 USD and a min estimate of 23.00 USD. Watch PGNY chart and read a more detailed Progyny, Inc. stock forecast: see what analysts think of Progyny, Inc. and suggest that you do with its stocks.
PGNY reached its all-time high on Nov 5, 2021 with the price of 68.32 USD, and its all-time low was 13.29 USD and was reached on Oct 25, 2019. View more price dynamics on PGNY chart.
See other stocks reaching their highest and lowest prices.
PGNY stock is 2.20% volatile and has beta coefficient of 0.48. Track Progyny, Inc. stock price on the chart and check out the list of the most volatile stocks — is Progyny, Inc. there?
Today Progyny, Inc. has the market capitalization of ‪1.89 B‬, it has decreased by −7.19% over the last week.
Yes, you can track Progyny, Inc. financials in yearly and quarterly reports right on TradingView.
Progyny, Inc. is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
PGNY earnings for the last quarter are 0.12 USD per share, whereas the estimation was 0.10 USD resulting in a 25.02% surprise. The estimated earnings for the next quarter are 0.19 USD per share. See more details about Progyny, Inc. earnings.
Progyny, Inc. revenue for the last quarter amounts to ‪298.43 M‬ USD, despite the estimated figure of ‪277.78 M‬ USD. In the next quarter, revenue is expected to reach ‪307.86 M‬ USD.
PGNY net income for the last quarter is ‪10.53 M‬ USD, while the quarter before that showed ‪10.42 M‬ USD of net income which accounts for 1.07% change. Track more Progyny, Inc. financial stats to get the full picture.
No, PGNY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 680 employees. See our rating of the largest employees — is Progyny, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Progyny, Inc. EBITDA is ‪70.63 M‬ USD, and current EBITDA margin is 6.05%. See more stats in Progyny, Inc. financial statements.
Like other stocks, PGNY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Progyny, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Progyny, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Progyny, Inc. stock shows the sell signal. See more of Progyny, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.